Cargando…

Prognostic value of tumor mutation burden in patients with advanced gastric cancer receiving first-line chemotherapy

BACKGROUND: Tumor mutation burden (TMB) is a promising biomarker positively associated with the benefit of immunotherapy and that might predict the outcome of chemotherapy. We described the prognostic value of TMB in advanced gastric cancer and explored the underlying mechanism. METHODS: We enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duan, Xiao-Peng, Liu, Ke, Jiao, Xiao-Dong, Qin, Bao-Dong, Li, Bing, He, Xi, Ling, Yan, Wu, Ying, Chen, Shi-Qi, Zang, Yuan-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847361/ https://www.ncbi.nlm.nih.gov/pubmed/36686739 http://dx.doi.org/10.3389/fonc.2022.1007146

Ejemplares similares

Prognostic value of fibrinogen-to-albumin ratio in patients with gastric cancer receiving first-line chemotherapy
por: Zhang, Liqun, et al.
Publicado: (2020)

Efficacy of Postoperative FOLFOX Versus XELOX Chemotherapy for Gastric Cancer and Prognostic Value of Platelet–Lymphocyte Ratio in Patients Receiving XELOX
por: Yin, Xin, et al.
Publicado: (2020)

Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy
por: Zheng, Chen, et al.
Publicado: (2023)

Preoperative Nutritional Status Contributes to the Development of Neutropenia Event in Patients With Gastric Cancer Receiving CAPEOX Adjuvant Chemotherapy
por: Xiao, Ai Tang, et al.
Publicado: (2020)

Predictive value of DNA methylation in the efficacy of chemotherapy for gastric cancer
por: Li, Ye, et al.
Publicado: (2023)

Basket Trials for Intractable Cancer
por: Qin, Bao-Dong, et al.
Publicado: (2019)

The Prognostic Value of Postoperative Lymph Node Ratio in Gastric Adenocarcinoma Patients Treated With Neoadjuvant Chemotherapy
por: Sakin, Abdullah, et al.
Publicado: (2021)

Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric Cancer
por: Xie, Jian-Wei, et al.
Publicado: (2021)

Prognostic value of different lymph node staging methods for node-positive cardia gastric cancer: a register-based retrospective cohort study
por: Wang, Xiao-Qing, et al.
Publicado: (2021)

Expression and clinical value of circRNAs in serum extracellular vesicles for gastric cancer
por: Xiao, Ke, et al.
Publicado: (2022)

A Nomogram for Predicting Risk of Thromboembolism in Gastric Cancer Patients Receiving Chemotherapy
por: Yuan, Hai-Liang, et al.
Publicado: (2021)

Prognostic value of neutrophil to lymphocyte ratio in gastric cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
por: Zhang, Siheng, et al.
Publicado: (2023)

Role of neutrophil-to-lymphocyte ratio as a prognostic biomarker in patients with breast cancer receiving neoadjuvant chemotherapy: a meta-analysis
por: Zhou, Qiong, et al.
Publicado: (2021)

Prognostic Value of Changes in Preoperative and Postoperative Serum CA19-9 Levels in Gastric Cancer
por: Song, Xiao-Hai, et al.
Publicado: (2020)

A Novel Inflammatory-Nutritional Prognostic Scoring System for Stage III Gastric Cancer Patients With Radical Gastrectomy Followed by Adjuvant Chemotherapy
por: Wang, Nan, et al.
Publicado: (2021)

In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator
por: Chen, Li, et al.
Publicado: (2021)

Prognostic Value of Postoperative Circulating Tumor DNA in Patients With Early- and Intermediate-Stage Hepatocellular Carcinoma
por: Ye, Ke, et al.
Publicado: (2022)

The Prognostic Value of Adjuvant Chemotherapy in Colon Cancer With Solitary Tumor Deposit
por: Lin, Qiangkang, et al.
Publicado: (2022)

Prognostic Value of Regression Rate of Plasma EBV DNA After Induction Chemotherapy for Stage II-IVA Nasopharyngeal Carcinoma
por: Peng, Hao, et al.
Publicado: (2021)

Identification and Validation of SNP-Containing Genes With Prognostic Value in Gastric Cancer via Integrated Bioinformatics Analysis
por: Li, Hui, et al.
Publicado: (2021)

The Prognostic Value of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma
por: Meng, Wangyang, et al.
Publicado: (2021)

Oligorecurrence Non–small Cell Lung Cancer After Failure of First-Line Chemotherapy: Computed Tomography–Guided (125)I Seed Implantation vs. Second-Line Chemotherapy
por: Wang, Hao, et al.
Publicado: (2020)

Three-Tier Prognostic Index in Young Adults With Advanced Gastric Cancer
por: Chen, Guang-Liang, et al.
Publicado: (2021)

Complete remission in a patient with metastatic gastric cancer receiving tislelizumab combined with chemotherapy: a case report
por: Zhu, Zhe, et al.
Publicado: (2023)

Immune checkpoint inhibitors alone or in combination with chemotherapy for treatment of advanced non-small cell lung cancer after first-line platinum-based chemotherapy: A propensity score matching analysis
por: Qiu, Lupeng, et al.
Publicado: (2022)

Prognostic Value of Deep Learning-Mediated Treatment Monitoring in Lung Cancer Patients Receiving Immunotherapy
por: Trebeschi, Stefano, et al.
Publicado: (2021)

Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?
por: Huang, Jiao-Bao, et al.
Publicado: (2021)

Incremental prognostic value of ADC histogram analysis in patients with high-risk prostate cancer receiving adjuvant hormonal therapy after radical prostatectomy
por: He, Kangwen, et al.
Publicado: (2023)

Prognostic Evaluation of Metastasis-Related Lymphocyte/Monocyte Ratio in Stage Ⅰ-Ⅲ Breast Cancer Receiving Chemotherapy
por: Zhang, Zihan, et al.
Publicado: (2022)

Identifying Prognostic Markers From Clinical, Radiomics, and Deep Learning Imaging Features for Gastric Cancer Survival Prediction
por: Hao, Degan, et al.
Publicado: (2022)

Prognostic Value of Vimentin Is Associated With Immunosuppression in Metastatic Renal Cell Carcinoma
por: Yao, Jia xi, et al.
Publicado: (2020)

Prognostic Value of the Pretreatment Lung Immune Prognostic Index in Advanced Small Cell Lung Cancer Patients Treated With First-Line PD-1/PD-L1 Inhibitors Plus Chemotherapy
por: Li, Lingling, et al.
Publicado: (2021)

Association of inflammatory markers with survival in patients with advanced gastric cancer treated with immune checkpoint inhibitors combined with chemotherapy as first line treatment
por: Wan, Mingyu, et al.
Publicado: (2022)

Comprehensive Analysis of Immune Implications and Prognostic Value of SPI1 in Gastric Cancer
por: Huang, Jianfeng, et al.
Publicado: (2022)

Prognostic value of computed tomography radiomics features in patients with gastric neuroendocrine neoplasm
por: Yang, Zhi-hao, et al.
Publicado: (2023)

Identification of Novel Immune Ferropotosis-Related Genes Associated With Clinical and Prognostic Features in Gastric Cancer
por: Xiao, Chen, et al.
Publicado: (2022)

Predictive value of NLR and PLR in response to preoperative chemotherapy and prognosis in locally advanced gastric cancer
por: Wang, Wentao, et al.
Publicado: (2022)

Prognostic Values of TIM-3 Expression in Patients With Solid Tumors: A Meta-Analysis and Database Evaluation
por: Qin, Shuang, et al.
Publicado: (2020)

Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors
por: Roviello, Giandomenico, et al.
Publicado: (2022)

LASTR is a novel prognostic biomarker and predicts response to cancer immunotherapy in gastric cancer
por: Liu, Jun-Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oveb38ed8lvo11versts6mhfic